Strategic Biopharmaceutical Company: Using Data Migration to Close Gaps
Bio Pharm Company’s Multi-Billion Dollar Strategic Project
Our client’s scientific focus has resulted in 19 marketed products that are benefiting hundreds of thousands of people, a pipeline of late-stage drug candidates and unmatched patient access programs to ensure medications are available to those who could not otherwise afford them.
Today, the research and development effort is the largest it has ever been and includes approximately 200 clinical studies evaluating compounds with the potential to become the next generation of innovative therapies for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions.